Cargando…
Type I IFNs and CD8 T cells increase intestinal barrier permeability after chronic viral infection
Intestinal barrier leakage constitutes a potential therapeutic target for many inflammatory diseases and represents a disease progression marker during chronic viral infections. However, the causes of altered gut barrier remain mostly unknown. Using murine infection with lymphocytic choriomeningitis...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953738/ https://www.ncbi.nlm.nih.gov/pubmed/32880630 http://dx.doi.org/10.1084/jem.20192276 |
_version_ | 1783663975359053824 |
---|---|
author | Labarta-Bajo, Lara Nilsen, Steven P. Humphrey, Gregory Schwartz, Tara Sanders, Karenina Swafford, Austin Knight, Rob Turner, Jerrold R. Zúñiga, Elina I. |
author_facet | Labarta-Bajo, Lara Nilsen, Steven P. Humphrey, Gregory Schwartz, Tara Sanders, Karenina Swafford, Austin Knight, Rob Turner, Jerrold R. Zúñiga, Elina I. |
author_sort | Labarta-Bajo, Lara |
collection | PubMed |
description | Intestinal barrier leakage constitutes a potential therapeutic target for many inflammatory diseases and represents a disease progression marker during chronic viral infections. However, the causes of altered gut barrier remain mostly unknown. Using murine infection with lymphocytic choriomeningitis virus, we demonstrate that, in contrast to an acute viral strain, a persistent viral isolate leads to long-term viral replication in hematopoietic and mesenchymal cells, but not epithelial cells (IECs), in the intestine. Viral persistence drove sustained intestinal epithelial barrier leakage, which was characterized by increased paracellular flux of small molecules and was associated with enhanced colitis susceptibility. Type I IFN signaling caused tight junction dysregulation in IECs, promoted gut microbiome shifts and enhanced intestinal CD8 T cell responses. Notably, both type I IFN receptor blockade and CD8 T cell depletion prevented infection-induced barrier leakage. Our study demonstrates that infection with a virus that persistently replicates in the intestinal mucosa increases epithelial barrier permeability and reveals type I IFNs and CD8 T cells as causative factors of intestinal leakage during chronic infections. |
format | Online Article Text |
id | pubmed-7953738 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-79537382021-06-07 Type I IFNs and CD8 T cells increase intestinal barrier permeability after chronic viral infection Labarta-Bajo, Lara Nilsen, Steven P. Humphrey, Gregory Schwartz, Tara Sanders, Karenina Swafford, Austin Knight, Rob Turner, Jerrold R. Zúñiga, Elina I. J Exp Med Article Intestinal barrier leakage constitutes a potential therapeutic target for many inflammatory diseases and represents a disease progression marker during chronic viral infections. However, the causes of altered gut barrier remain mostly unknown. Using murine infection with lymphocytic choriomeningitis virus, we demonstrate that, in contrast to an acute viral strain, a persistent viral isolate leads to long-term viral replication in hematopoietic and mesenchymal cells, but not epithelial cells (IECs), in the intestine. Viral persistence drove sustained intestinal epithelial barrier leakage, which was characterized by increased paracellular flux of small molecules and was associated with enhanced colitis susceptibility. Type I IFN signaling caused tight junction dysregulation in IECs, promoted gut microbiome shifts and enhanced intestinal CD8 T cell responses. Notably, both type I IFN receptor blockade and CD8 T cell depletion prevented infection-induced barrier leakage. Our study demonstrates that infection with a virus that persistently replicates in the intestinal mucosa increases epithelial barrier permeability and reveals type I IFNs and CD8 T cells as causative factors of intestinal leakage during chronic infections. Rockefeller University Press 2020-09-03 /pmc/articles/PMC7953738/ /pubmed/32880630 http://dx.doi.org/10.1084/jem.20192276 Text en © 2020 Labarta-Bajo et al. http://www.rupress.org/terms/https://creativecommons.org/licenses/by-nc-sa/4.0/This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms/). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 International license, as described at https://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Article Labarta-Bajo, Lara Nilsen, Steven P. Humphrey, Gregory Schwartz, Tara Sanders, Karenina Swafford, Austin Knight, Rob Turner, Jerrold R. Zúñiga, Elina I. Type I IFNs and CD8 T cells increase intestinal barrier permeability after chronic viral infection |
title | Type I IFNs and CD8 T cells increase intestinal barrier permeability after chronic viral infection |
title_full | Type I IFNs and CD8 T cells increase intestinal barrier permeability after chronic viral infection |
title_fullStr | Type I IFNs and CD8 T cells increase intestinal barrier permeability after chronic viral infection |
title_full_unstemmed | Type I IFNs and CD8 T cells increase intestinal barrier permeability after chronic viral infection |
title_short | Type I IFNs and CD8 T cells increase intestinal barrier permeability after chronic viral infection |
title_sort | type i ifns and cd8 t cells increase intestinal barrier permeability after chronic viral infection |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953738/ https://www.ncbi.nlm.nih.gov/pubmed/32880630 http://dx.doi.org/10.1084/jem.20192276 |
work_keys_str_mv | AT labartabajolara typeiifnsandcd8tcellsincreaseintestinalbarrierpermeabilityafterchronicviralinfection AT nilsenstevenp typeiifnsandcd8tcellsincreaseintestinalbarrierpermeabilityafterchronicviralinfection AT humphreygregory typeiifnsandcd8tcellsincreaseintestinalbarrierpermeabilityafterchronicviralinfection AT schwartztara typeiifnsandcd8tcellsincreaseintestinalbarrierpermeabilityafterchronicviralinfection AT sanderskarenina typeiifnsandcd8tcellsincreaseintestinalbarrierpermeabilityafterchronicviralinfection AT swaffordaustin typeiifnsandcd8tcellsincreaseintestinalbarrierpermeabilityafterchronicviralinfection AT knightrob typeiifnsandcd8tcellsincreaseintestinalbarrierpermeabilityafterchronicviralinfection AT turnerjerroldr typeiifnsandcd8tcellsincreaseintestinalbarrierpermeabilityafterchronicviralinfection AT zunigaelinai typeiifnsandcd8tcellsincreaseintestinalbarrierpermeabilityafterchronicviralinfection |